MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581

Completed
Conditions
Colorectal Cancer
Interventions
Procedure: laboratory biomarker analysis
First Posted Date
2009-05-12
Last Posted Date
2019-02-19
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
2059
Registration Number
NCT00897429
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer

Withdrawn
Conditions
Head and Neck Cancer
Interventions
Genetic: microarray analysis
Genetic: allele-specific oligonucleotide real-time quantitative polymerase chain reaction
Other: diagnostic laboratory biomarker analysis
First Posted Date
2009-05-12
Last Posted Date
2019-01-30
Lead Sponsor
Alliance for Clinical Trials in Oncology
Registration Number
NCT00899704
Locations
🇺🇸

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Completed
Conditions
Brain and Central Nervous System Tumors
Interventions
Genetic: gene expression analysis
Genetic: microarray analysis
Genetic: protein expression analysis
Other: diagnostic laboratory biomarker analysis
Other: immunohistochemistry staining method
First Posted Date
2009-05-12
Last Posted Date
2018-01-24
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
56
Registration Number
NCT00897663
Locations
🇺🇸

Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States

🇺🇸

Mayo Clinic Scottsdale, Scottsdale, Arizona, United States

🇺🇸

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

and more 7 locations

Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes

Active, not recruiting
Conditions
Chronic Leukemia
Myelodysplasia
Acute Leukemia
Interventions
Other: biologic sample preservation procedure
First Posted Date
2009-05-12
Last Posted Date
2024-07-31
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
1500
Registration Number
NCT00899223
Locations
🇺🇸

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

🇺🇸

Illinois CancerCare - Canton, Canton, Illinois, United States

🇺🇸

Eureka Community Hospital, Eureka, Illinois, United States

and more 138 locations

Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer

Completed
Conditions
Breast Cancer
First Posted Date
2009-05-12
Last Posted Date
2017-08-08
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
1500
Registration Number
NCT00899509
Locations
🇺🇸

Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States

🇺🇸

Mercy Medical Center - Sioux City, Sioux City, Iowa, United States

🇺🇸

St. Luke's Regional Medical Center, Sioux City, Iowa, United States

Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344

Completed
Conditions
Breast Cancer
Interventions
Genetic: fluorescence in situ hybridization
Other: immunohistochemistry staining method
First Posted Date
2009-05-12
Last Posted Date
2021-08-17
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
1195
Registration Number
NCT00897026
Locations
🇺🇸

Washington University, Saint Louis, Missouri, United States

Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

Terminated
Conditions
Malignant Mesothelioma
Interventions
Other: immunoenzyme technique
Other: laboratory biomarker analysis
First Posted Date
2009-05-12
Last Posted Date
2019-01-24
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
47
Registration Number
NCT00898547

Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer

Completed
Conditions
Lung Cancer
Interventions
Genetic: molecular diagnostic method
Genetic: mutation analysis
First Posted Date
2009-05-12
Last Posted Date
2016-06-29
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
60
Registration Number
NCT00898924

Study of Tumor Samples From Patients With Lung Cancer

Completed
Conditions
Lung Cancer
Interventions
Other: laboratory biomarker analysis
First Posted Date
2009-05-12
Last Posted Date
2017-08-08
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
280
Registration Number
NCT00900328
Locations
🇺🇸

University of Chicago, Boston, Massachusetts, United States

Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

Completed
Conditions
Leukemia
Interventions
Other: flow cytometry
Other: immunologic technique
Other: laboratory biomarker analysis
First Posted Date
2009-05-12
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
451
Registration Number
NCT00896701
Locations
🇺🇸

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

🇺🇸

Kinston Medical Specialists, Kinston, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath